Tumoren der Mittellinie bei Kindern

Chapter

Zusammenfassung

Das Management der Mittellinientumoren bei Kinder bedarf eines interdisziplinäres Ansatzes, wobei in den meisten Fälle die mikrochirurgische Entfernung eine wesentliche Rolle spielt. Nur die diffus wachsenden hypothalamen und bithalamischen Tumoren sowie die optochiasmalen Tumoren (bei erhaltenem Visus oder im Ramen einer Neurofibromatose) und die strahlensensiblen Germinome stellen Ausnahmen dar. Durch ihre Lokalisation in eloquenten Strukturen ist eine detaillierte präoperative Planung jedoch absolut notwendig. Um Komplikationen zu vermeiden, muss die Neuroanatomie des Patienten und die Lokalisation des Tumors genau evaluiert werden, um den richtigen Zugangsweg zu wählen. Nur so kann eine ungünstige intraoperative Situation durch schlechte Visualisation der Tumorgrenzen und toter Winkel vermieden werden.

Literatur

  1. Aizer AA, Ancukiewicz M, Nguyen PL, Macdonald SM, Yock TI, Tarbell NJ, Shih HA, Loeffler JS, Oh KS (2013) Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol 115:411–419CrossRefGoogle Scholar
  2. Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME, Robison LL, Gajjar A, Morris EB (2011) Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol 13:223–234CrossRefGoogle Scholar
  3. Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK, Gilbertson RJ (2011) An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell 20:384–399CrossRefGoogle Scholar
  4. Burkhard C, Di Patre PL, Schüler D, Yaşargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H (2003) A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 98:1170–1174CrossRefGoogle Scholar
  5. Crino PB, Henske EP (1999) New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53:1384–1390CrossRefGoogle Scholar
  6. Deiana G, Mottolese C, Hermier M, Louis-Tisserand G, Bertezene Y (2015) Imagery of pineal tumors. Neurochirurgie 61: 113–122CrossRefGoogle Scholar
  7. Ess KC, Kamp CA, Tu BP, Gutmann DH (2005) Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex. Neurology 64:1446–1449CrossRefGoogle Scholar
  8. Faure-Conter C (2015) Tumoral markers in tumors of the pineal region. Neurochirurgie 61: 143–145CrossRefGoogle Scholar
  9. Fernandez C, Figarella-Branger D, Girard N, Bouvier-Labit C, Gouvernet J, Paz Paredes A, Lena G (2003) Pilocytic astrocytomas in children: prognostic factors–a retrospective study of 80 cases. Neurosurgery 53:544–553CrossRefGoogle Scholar
  10. Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461CrossRefGoogle Scholar
  11. Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P, Kalifa C; French Society of Pediatric Oncology (2001) Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19:1288–1296Google Scholar
  12. Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol 8:696–705Google Scholar
  13. Hassoun J, Söylemezoglu F, Gambarelli D, Figarella-Branger D, von Ammon K, Kleihues P (1993) Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3:297–306CrossRefGoogle Scholar
  14. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466:632–636CrossRefGoogle Scholar
  15. Kim CY, Paek SH, Jeong SS, Chung HT, Han JH, Park CK, Jung HW, Kim DG (2007) Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment. Cancer 110:2276–2284CrossRefGoogle Scholar
  16. Kocaoglu M, Ors F, Bulakbasi N, Onguru O, Ulutin C, Secer HI (2009) Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings. Magn Reson Imaging 27:434–440CrossRefGoogle Scholar
  17. Krieger MD, Gonzalez-Gomez I, Levy ML, McComb JG (1997) Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 27:1–11CrossRefGoogle Scholar
  18. Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:255–265Google Scholar
  19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefGoogle Scholar
  20. Mazloom A, Wolff JE, Paulino AC (2010) The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiat Oncol Biol Phys 78:79–84CrossRefGoogle Scholar
  21. Mottolese C, Szathmari A, Beuriat PA (2015) Incidence of pineal tumours. A review of the literature. Neurochirurgie; 61: 65–69PubMedGoogle Scholar
  22. Needle MN, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P, Sutton L, Zhao H, Garvin JH Jr, Phillips PC (1997) Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 80:341–347CrossRefGoogle Scholar
  23. O'Callaghan FJ, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP (2008) Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child 93:751–754CrossRefGoogle Scholar
  24. Paek SH, Han JH, Kim JW, Park CK, Jung HW, Park SH, Kim IH, Kim DG (2008) Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol 90:25–30CrossRefGoogle Scholar
  25. Palma L, Celli P, Mariottini A, Zalaffi A, Schettini G (2000) The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv Syst 16:170–175CrossRefGoogle Scholar
  26. Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, Lee R, Tatevossian RG, Phoenix TN, Thiruvenkatam R, White E, Tang B, Orisme W, Gupta K, Rusch M, Chen X, Li Y, Nagahawhatte P, Hedlund E, Finkelstein D, Wu G, Shurtleff S, Easton J, Boggs K, Yergeau D, Vadodaria B, Mulder HL, Becksfort J, Gupta P, Huether R, Ma J, Song G, Gajjar A, Merchant T, Boop F, Smith AA, Ding L, Lu C, Ochoa K, Zhao D, Fulton RS, Fulton LL, Mardis ER, Wilson RK, Downing JR, Green DR, Zhang J, Ellison DW, Gilbertson RJ (2014) C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506:451–455CrossRefGoogle Scholar
  27. Pérez-Martínez A, Lassaletta A, González-Vicent M, Sevilla J, Díaz MA, Madero L (2005) High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 71:33–38CrossRefGoogle Scholar
  28. Pietsch T, Wohlers I, Goschzik T, Dreschmann V, Denkhaus D, Dörner E, Rahmann S, Klein-Hitpass L (2014) Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway. Acta Neuropathol 127:609–611CrossRefGoogle Scholar
  29. Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ (2000) Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88:2189–2193CrossRefGoogle Scholar
  30. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ, Wisoff J (1998) Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88:695–703CrossRefGoogle Scholar
  31. Timmermann B, Kortmann RD, Kühl J, Rutkowski S, Meisner C, Pietsch T, Deinlein F, Urban C, Warmuth-Metz M, Bamberg M (2006) Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 24:1554–1560CrossRefGoogle Scholar
  32. Trebinska J, Dachowska I, Kotulska K, Baranska D, Fendler W, Jozwiak S, Mynarski W (2015) Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis. Pediatr Blood Cancer 62:616–621CrossRefGoogle Scholar
  33. van Veelen-Vincent ML, Pierre-Kahn A, Kalifa C, Sainte-Rose C, Zerah M, Thorne J, Renier D (2002) Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 97:827–835CrossRefGoogle Scholar
  34. Wrede B, Liu P, Wolff JE (2007) Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol 85:345–351CrossRefGoogle Scholar
  35. Wrede B, Hasselblatt M, Peters O, Thall PF, Kutluk T, Moghrabi A, Mahajan A, Rutkowski S, Diez B, Wang X, Pietsch T, Kortmann RD, Paulus W, Jeibmann A, Wolff JE (2009) Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol 95:383–392CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2018

Authors and Affiliations

  1. 1.Department of NeurosurgeryUZ BrusselBrusselBelgium

Personalised recommendations